As debate continues over how artificial intelligence will disrupt—or enhance—the delivery of financial services, one major AI platform is deepening its ability to integrate personal financial data.

Stanley Druckenmiller says artificial intelligence is no longer playing a starring role in his investments, as he focuses more on hard assets like copper and a more diversified portfolio of stocks.

A great income portfolio needs more than high dividends. Here's how I'd combine quality shares, infrastructure, and ETFs to build long-term income. You’re reading a free article with opinions that may ...

Investors are still coming out of one of the worst bond markets in history. Between the bond market’s dismal 2022 and the stock market’s downturn from the onset of the Russia-Ukraine war, the 2020s ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Simon Property Group, the largest mall real estate investment trust, manages one of the top retail portfolios in the country. It owns and operates Class A traditional regional malls and premium ...

American Century Investments One Choice 2055 Portfolio R Class 13.96 American Century Investments One Choice 2055 Portfolio A Class 14.27 American Century Investments ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

The so-called “baby” G-Class is a long overdue product that we first heard about a few good years back, but make no mistake, this model is indeed coming and will launch sooner rather than later. We ...

Mercedes-Benz and minivans are two terms that are virtually never seen together, at least not in the U.S. market, but the new VLE class changes that. Smaller than the commercial-focused Sprinter, the ...

Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro, in vivo and non-human primate study results, that support development ...